Drug Monitoring, Barbiturates, with Confirmation, Urine

There are no preparation instructions.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Amobarbital

Barbiturates

Butalbital

Medmatch Barbiturates

Pentobarbital

Phenobarbital

Secobarbital

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through a national lab. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The Drug Monitoring, Barbiturates, with Confirmation, Urine test contains 1 test with 7 biomarkers.

Drug Monitoring, Barbiturates, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Barbiturates, with Confirmation, Urine - The barbiturate class of drugs are traditionally classified as sedatives and central nervous system depressants. Their principle uses are to calm the patient, produce drowsiness, and/or promote sleep. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring of the barbiturates is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Barbiturates drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80345; HCPCS: G0480).
Confirmation includes the following analytes: Amobarbital, Butalbital, Pentobarbital, Phenobarbital, Secobarbital

Reference Range(s)
Barbiturates    <300 ng/mL
  Amobarbital    <100 ng/mL
  Butalbital    <100 ng/mL
  Pentobarbital    <100 ng/mL
  Phenobarbital    <100 ng/mL
  Secobarbital    <100 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Customer Reviews